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Cachexia, characterized by loss of skeletal muscle mass, is a major contributory factor to patient 
morbidity and mortality during cancer. The intracellular regulation of muscle wasting is affected 
by the muscle’s capacity for oxidative metabolism. However, there are no reports on the rate of 
myofibrillar protein synthesis (MPS) in skeletal muscles that vary in primary metabolic 
phenotype during cachexia, in large part because of the small size of plantaris and soleus 
muscle, and regional differences in larger muscles in the mouse. In this paper we describe a 
sensitive method for measurement of MPS in murine tissue and apply this measurement to 
analysis of myofibrillar protein synthesis in specific muscles of mice with and without colon 
cancer cachexia. 
A mouse model of colorectal cancer cachexia (Apc
Min/+
) and their controls (C57BL/6) 
were injected with a loading dose of deuterated phenylalanine (D5F) and myofibrillar proteins 
extracted from skeletal muscles at 30 min. The relative concentrations of D5F and naturally 
occurring phenylalanine (F) in the myofibrillar proteins and the amino acid pool from 5 mg wet 
weight of muscle were quantified on an ultra performance liquid chromatograph (UPLC), 
coupled to an electro-spray triple quadruple mass spectrometer operated in multiple reaction 
monitoring mode. The rate of MPS was determined from the ratio of D5F: F in the protein 
fraction, compared to the amino acid pool. 
The rate of MPS, measured in 2-5 mg muscle protein, was reduced by  65% in cachectic 
Apc
Min/+
 compared to the control C57BL/6 mice in the soleus, plantaris, oxidative (red) and 
glycolytic (white) regions of the gastrocnemius, and diaphragm. The rate of MPS was 
significantly higher in the oxidative vs. glycolytic gastrocnemius muscle.  
A sensitive UPLC-MS method has been developed to measure the rate of MPS in mouse 
muscles. The method does not require chemical derivatization of the analyte and is sufficiently 
sensitive that it can be applied for analysis of MPS in 2-5 mg quantities of mouse 
gastrocnemius, soleus, plantaris, diaphragm and other muscle.  This method could be further 
applied to other animal models for quantifying effects of cancer and cancer therapies on 
protein synthesis in cachexia. 
 
